Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Dova Pharmaceuticals, Inc. (DOVA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2019 |
4
| Stalfort Sean (Director) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Unknown transaction of 635,665 shares
@ $27.5, valued at
$17.5M
|
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2019 |
4
| Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Disposed/sold 4,761 shares
@ $0
Disposed/sold 115,500 options to buy
@ $3.73, valued at
$430.8k
Disposed/sold 24,750 options to buy
@ $3.73, valued at
$92.3k
Disposed/sold 50,000 options to buy
@ $8.82, valued at
$441k
Disposed/sold 10,000 options to buy
@ $16.08, valued at
$160.8k
|
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2019 |
4
| Hoitt Jason (Chief Commercial Officer) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Disposed/sold 9,970 shares
@ $0
Disposed/sold 250,000 options to buy
@ $6.07, valued at
$1.5M
|
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Hoitt Jason (Chief Commercial Officer) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 2,387 shares
@ $28, valued at
$66.8k
|
|
| 10/02/2019 |
4
| Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 3,100 shares
@ $28, valued at
$86.8k
Sold 596 shares
@ $28, valued at
$16.7k
|
|
| 09/27/2019 |
4
| Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 3,100 shares
@ $20, valued at
$62k
|
|
| 08/12/2019 |
4
| Manning Paul B (10% Owner) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Bought 28,062 shares
@ $15.87, valued at
$445.3k
|
|
| 08/01/2019 |
4
| Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 1,389 shares
@ $15.97, valued at
$22.2k
Granted 10,000 options to buy
@ $16.08, valued at
$160.8k
|
|
| 08/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/16/2019 |
4
| Hoitt Jason (Chief Commercial Officer) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 6,680 shares
@ $15.1, valued at
$100.9k
Sold 900 shares
@ $16.44, valued at
$14.8k
|
|
| 07/11/2019 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Bought 29,834 shares
@ $16.61, valued at
$495.5k
Bought 12,354 shares
@ $16.89, valued at
$208.7k
Bought 42,916 shares
@ $16.67, valued at
$715.4k
|
|
| 07/09/2019 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Bought 50,000 shares
@ $16.46, valued at
$823k
|
|
| 07/03/2019 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Bought 18,121 shares
@ $14.24, valued at
$258k
Bought 715 shares
@ $16.14, valued at
$11.5k
Bought 1,705 shares
@ $16.67, valued at
$28.4k
|
|
| 07/03/2019 |
4
| ZACCARDELLI DAVID (President & CEO) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 5,899 shares
@ $15.73, valued at
$92.8k
Sold 4,551 shares
@ $16.22, valued at
$73.8k
|
|
| 07/02/2019 |
4
| Hahn Mark W (CFO) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 1,545 shares
@ $14.17, valued at
$21.9k
|
|
| 07/02/2019 |
4
| JEFFS ROGER (Director) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 1,308 shares
@ $14.17, valued at
$18.5k
|
|
| 07/02/2019 |
4
| Laliberte Kevin (Sr. VP, Product Development) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 1,191 shares
@ $14.17, valued at
$16.9k
|
|
| 07/02/2019 |
4
| ALLEN LEE F MD PhD (Chief Medical Officer) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 1,957 shares
@ $14.19, valued at
$27.8k
|
|
| 07/02/2019 |
4
| Hoitt Jason (Chief Commercial Officer) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Sold 2,237 shares
@ $13.77, valued at
$30.8k
Sold 150 shares
@ $14.4, valued at
$2.2k
|
|
| 07/01/2019 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on Dova Pharmaceuticals Inc.|
Txns:
| Bought 140,513 shares
@ $12.46, valued at
$1.8M
Bought 186,696 shares
@ $13.58, valued at
$2.5M
Bought 60,617 shares
@ $13.97, valued at
$846.8k
Bought 39,383 shares
@ $14.48, valued at
$570.3k
|
|
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|